David M. Goldenberg, SC.D., M.D., [Chairman]; A. Munro Neville, M.D., PH.D. [Rapporteur]; Anne C. Carter, M.D.; Vay Liang W. Go, M.D.; Edward Douglas Hol-yoke, M.D.; Kurt J. Isselbacher, M.D.; Philip S. Schein, M.D.; Morton Schwartz, PH.D.
This content is PDF only. Please click on the PDF icon to access.
A consensus development conference was held 29 September to 1 October 1980, at the National Institutes of Health, to address issues concerning the role of carcinoembryonic antigen (CEA) as a marker in the management of cancer. This conference was sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, Office of the Director, NIH.
For this conference, the members of the panel were limited to biomedical and clinical investigators actively working the field, clinically involved in patient care, and familiar with the technology under assessment. The panel met after the formal presentations and discussions to
David M. Goldenberg, A. Munro Neville, Anne C. Carter, Vay Liang W. Go, Edward Douglas Hol-yoke, Kurt J. Isselbacher, et al. Carcinoembryonic Antigen: Its Role as a Marker in the Management of Cancer. A National Institutes of Health Consensus Development Conference. Ann Intern Med. 1981;94:407–409. doi: 10.7326/0003-4819-94-3-407
Download citation file:
Published: Ann Intern Med. 1981;94(3):407-409.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use